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Abstract A 1932 bp cDNA clone encoding a novel isozyme of 6- 
phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/ 
FBPase-2) was isolated from a mouse kidney cDNA library. 
The sequence ncodes 519 amino acids and, based on homology 
to rat heart genomic sequence, appears to be the product of 
alternative splicing from PFK-2/FBPase-2 gene B with an 
extended version of exon 15. Northern blot analysis indicated 
that this clone corresponds to an 8 kb mRNA expressed in 
multiple tissues, with the strongest signal in kidney, and detects 
several additional transcripts which may be alternatively spliced 
from gene B. 
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I. Introduction 
Fructose 2,6-bisphosphate (Fru-2,6-P2) plays a key role in 
the regulation of glycolysis by acting as a potent allosteric 
activator of the rate-determining enzyme, phosphofructoki- 
nase (PFK-1; EC 2.7.1.11). Unlike other regulatory elements 
of PFK-1, such as ATP, which are synthesized irectly in the 
glycolytic pathway, Fru-2,6-P2 is synthesized and broken 
down by a separate, specific enzyme, 6-phosphofructo-2- 
kinase/fructose-2,6-bisphosphatase (PFK-2; EC 2.7.1.105/ 
FBPase-2; EC 3.1.3.46). The bifunctional enzyme functions 
as a homodimer with two distinct catalytic sites on each iden- 
tical polypeptide chain [1,2]. 
Studies to date have revealed a complex system of genetic 
organization, with five mammalian isozyme forms identified, 
referred to as liver [3], skeletal muscle [4], heart [5], testis [6], 
and brain [7,8], based on their tissue prevalence. The isozymes 
are encoded by at least two distinct genes which have been 
characterized (genes A and B), and possibly as many as four. 
In rat, gene A is a 60 kb X-linked locus encoding the liver, 
muscle and fetal isozyme transcripts [9,10], while gene B is a 
22 kb autosomal locus encoding the heart isozyme [11]. PFK-  
2/FBPase-2 is one of only five known bifunctional enzymes 
which catalyze opposing reactions and is unique because it is 
the only one whose target is a metabolite rather than a protein 
[12]. 
The cellular concentration of Fru-2,6-P2 depends on the 
balance between kinase and phosphatase activities. This bal- 
ance has been shown to be regulated by a number of meta- 
bolic and hormonal signals which act through differential 
phosphorylation and dephosphorylation of the enzyme. The 
isozymes differ in their tissue-specific expression and response 
to hormonal signals, and a combination of isozymes derived 
from both of the identified PFK-2/FBPase-2 loci may be si- 
multaneously present as determined by the distinct metabolic 
needs of a particular tissue [13]. The related role of the en- 
zyme in kidney, as compared to liver, would suggest various 
isozyme types to be present in this tissue; however, which 
PFK-2/FBPase-2 loci are expressed in kidney has remained 
ambiguous. A study in which 40% of kidney PFK-2/ 
FBPase-2 was precipitated by antiserum to the liver enzyme 
[14] indicated a close relationship between the isozyme types 
present in these tissues. In addition, dot-blot experiments on 
total RNA indicated that liver-type isozyme was present at a 
low level in kidney, while muscle-type isozyme was present at 
a fairly substantial level [15]. On the other hand, Northern 
analysis has suggested that gene A is not at all expressed in 
kidney [16], and this premise has been used as the basis for an 
experiment on tissue-specific promoters [17]. Here we report 
the screening of a mouse kidney cDNA library in order to 
study the PFK-2/FBPase-2 isozymes present in this tissue, and 
the isolation of a novel full-length heart-type isozyme which 
appears to be the product of alternative splicing from gene B 
and is preferentially expressed in kidney. 
2. Materials and methods 
2.1. Materials 
Bacterial media were from Difco. Hybond N+ membranes, [c~- 
32P]dCTP, [0~-:~SS]dATP, and dNTPs were from Amersham. Klenow 
DNA polymerase and T4 DNA ligase were from Gibco-BRL. Seque- 
nase version 2.0 enzyme and kit were from USB. Wizard lambda 
minipreps and Taq polymerase were from Promega. The ~,gtl0 mouse 
kidney cDNA library and multiple tissue mouse Northern blot were 
from Clontech. One Shot competent cells and TA cloning kit were 
from Invitrogen. A mouse brain cDNA preparation made by oli- 
go(dT) priming and PCR amplification was the gift of Dr. J. Bristulf 
(Genetics Laboratory, Oxford). All other materials were reagent grade 
and obtained from commercial sources. 
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The nucleotide sequences presented here have been submitted to the 
EMBL/Genbank database under the accession numbers X98847 
(2kbC5) and X98848 (500bC6). 
2.2. Isolation and sequencing of eDNA clones 
A ~,gtl0 mouse kidney cDNA library was screened with a 1.25 kb 
EcoRI fragment derived from the 3' portion of human liver PFK-2/ 
FBPase-2 cDNA [18]. Labeling was by random priming with [cz- 
~2P]dCTP [19]. Hybridization was carried out at 65°C in Church buf- 
fer [20], and washing at the same temperature was to a final stringency 
of 40 mM sodium phosphate, pH 7.210.1% SDS. Filters were exposed 
to Kodak XAR film with Kodak intensifying screens at -70°C. In- 
serts were subcloned into pUC9 using standard techniques [21]. Plas- 
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raids were sequenced on both strands using the dideoxy method [22] 
using universal and reverse primers as well as primers derived from 
the obtained sequence. 
2.3. Sequence analysis" 
All sequence analysis was performed using the GCG (Madison. WI) 
software package [23]. Multiple sequence alignments were carried out 
using the PILEUP program with default parameter settings. 
2.4. Confirmation of Y sequence of 2kbC5 by PCR 
Primers were designed which spanned from exon 15 to sequence 
previously identified as intronic [11]. RAG mouse genomic DNA, a 
cDNA preparation made from mouse brain, the original cDNA clone, 
and water controls were used as templates. As a control, primers were 
designed from exons 7 and 8 which spanned a 1 kb intron. Primer 
details were as follows (5' starting position is given with respect o 
nucleotide sequence in Fig. 2; 'reverse' primers are complementary to 
coding strand): exon 15, forward (20mer, starting at nucleotide 1486), 
extended exon 15, reverse (20mer, 1874), exon 7, forward (22met, 
502), exon 8, reverse (20mer, 671). Conditions were: 200 mM dNTPs, 
10 mM Tris-HCl, 5 mM KCI, 1.5 mM MgCI2, 1 mM each primer, 
Taq polymerase. Cycling parameters were 94°C, 5 min ('hot start'): 
94°C, 30 s; 62°C, 30 s; 74°C, 105 s; 32 cycles. Products were TA 
cloned according to the kit manufacturer's instructions and se- 
quenced. 
2.5. Northern-blot analysis 
A multiple tissue mouse Northern blot was prehybridized for 6 h at 
42°C in 5×SSPE, 10×Denhardt's solution, 2% SDS, 50% freshly 
deionized formamide and 100 gg/ml denatured salmon sperm and 
hybridized overnight at the same temperature with fresh solution con- 
taining s2p-labeled 2kbC5 cDNA insert. The filter was washed for 30 
min at room temperature with several changes of 2 × SSC/0.5% SDS, 
followed by 40 min at 50°C with one change of 0.1 × SSC/0.1% SDS, 
and then exposed to Kodak XAR film. 
3. Results 
3.1. Isolation and characterization of  cDNA clones 
Tertiary screening of the mouse kidney library with the 
cDNA encoding human liver 6-phosphofructo-2-kinase/fruc- 
tose-2,6-bisphosphatase [18] yielded two positive clones con- 
taining inserts sized approx. 0.5 and 2 kb, and designated 
500bC6 and 2kbC5, respectively. The different hybridization 
patterns of the two clones on genomic and hybrid DNA gave 
a preliminary indication that 500bC6 was derived from an X- 
linked locus and 2kbC5 was autosomal in origin (data not 
shown). Precise mapping of the loci is in progress. Sequencing 
reinforced this hypothesis as nucleotides 2-215 of 500bC6 are 
predicted to encode 72 amino acids which show extremely 
high homology to the 3' ends of rat liver (96% nucleotide, 
100% amino acid homology) [24] and human liver (82% nu- 
cleotide, 96% amino acid homology) [25] isozyme sequences; 
the fragment is therefore predicted to encode the mouse 
homologue (sequence submitted to EMBL/Genbank data- 
bases, accession o. X98848). Since the 3' end is common to 
liver and skeletal muscle isozymes [9], it is not clear at present 
which of these isozymes corresponds to the isolated tran- 
script; however, a previous study has shown the skeletal mus- 
cle isoform to be expressed at a higher level in kidney [15]. 
Sequence analysis of the 1932 bp clone 2kbC5 predicts a 
putative open reading frame (ORF) extending from nucleo- 
tides 37 to 1596 in reading frame +1 and terminating with a 
TAA. This would encode a protein of 519 amino acids (Fig. 
1). The 5' end of the 2kbC5 from nucleotides 1 to 1395 iden- 
tifies with published coding sequence of rat brain isozyme, 
which has been hypothesized to be encoded by an alterna- 
tively spliced message from gene B [8]. The 3' end from bases 
1396 to 1571 is homologous to the bovine heart-type isozyme, 
but also includes a region previously identified as intronic 
(bases 1572 1932) in the genomic sequence of the rat heart 
gene B [11]. An homologous 3' sequence has been observed in 
a partial sequence of a rat heart-type cDNA isolated from 
testis [6]. These homologies uggest that the 1932 bp clone 
is a heart-type isozyme alternatively spliced from PFK-2/ 
FBPase-2 gene B. 
Further comparison of the sequence to that of the rat geno- 
mic heart sequence (Genbank accession os: X65953, X65954, 
X65955, X65956, X65957, X65958, X61956) indicates that it 
includes 76 bp of non-coding exon 1, exons 2 14, an extended 
version of exon 15, and since it fails to use exon 15 splice sites, 
is devoid of exon 16. 
3.2. Col~[irmation of  2kbC5 3' sequence by PCR 
The presence of sequence previously identified as intronic at 
the 3' end of the 2kbC5 cDNA clone was tested to determine 
whether it was representative of an actual transcript or was a 
cloning artifact. PCR primers were designed which spanned 
from exon 15 (prior to the putative splice sites) to 335 bp 
beyond the start of 'intronic' sequence. These primers were 
used to amplify from genomic DNA, a cDNA preparation 
made from mouse brain (another tissue which would be ex- 
pected to have a high representation of heart-type isozyme), 
and the original cDNA clone. If the intronic sequence were 
normally spliced out and 2kbC5 represented an aberrant 
clone, the predicted product of size 389 bp would amplify 
only from genomic and the plasmid template and no product 
would be expected from an independent cDNA library (unless 
it were contaminated with genomic DNA)  (Fig. 2, top). As a 
control, primers were designed from exon 7 and 8 which 
spanned the 1 kb intron between them; on the same tem- 
plates, these primers would be expected to give a much larger 
product on the genomic template (1106 bp) than on processed 
cDNA (171 bp). The presence of two bands from the library 
template would indicate contamination by genomic DNA. 
This experiment yielded identical bands of the expected size 
(389 bp), from genomic DNA,  the mouse brain cDNA prep- 
aration, and the original clone, using the primers including 
intronic sequence from the 3' end of 2kbC5 (Fig. 2, bottom). 
These PCR products were cloned and sequenced and found to 
match the expected sequence derived from 2kbC5. This indi- 
cates that this variant of exon 15, including the 'intronic' 
sequence, is present in an independent cDNA preparation 
and does not represent a cloning artifact. Amplification using 
the control primers yielded a band of the expected 1106 bp 
size on genomic template as well as a 171 bp product derived 
from the processed sequence on the cDNA library and 2kbC5 
clone templates. No contamination from genomic DNA was 
Fig. 1. Complete nucleotide and predicted amino acid sequence of 
2kbC5. Nucleotides representing proposed coding region are capital- 
ized. Numbers on the left refer to nucleotide sequence while those 
on the right refer to deduced amino acid sequence given in single- 
letter code below the nucleotide sequence. Translation start and 
stop sites are in bold. Potential phosphorylation sites are under- 
lined: two sites for cAMP-dependent protein kinase (PKA) at Ser- 
469 and Ser-486 and a protein kinase C (PKC) phosphorylation site 
at Thr-478. These sites correspond to regulatory sites previously 
characterized in rat and bovine heart-type isozymes [11,26,28]. Exon 
prediction is based on homology to rat heart genomic sequence [11]. 
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Exon 1 I Exon 2 
1 gt agacagg t ca t agggt gcct cct ga agaact accATGTCTGAGAATAGTACATTTTCCACAGAAGACAGCTGC 
M S E N S T F S T E D S C 13 
{ Exon  3 
76 AACAGCAGCTATAAACCCCAC GCCT CAAATCT GCGAAGGGCAGGGAAGACATGC CATGGGCT CCTATATGACC 
N S S Y K P H A S N L R R A G K T C S W A S Y M T 38 
151 ~CTCCCC~CACTCATTGTTATGATTGGCTTGCCAGCCCGGGGT~GACTTATGTGTCT~GAAACT~CACGC 
N S P T L I V M I G L P A R G K T Y V S K K L T R  63 
I Exon 4 
226 TACCTC~CTG~TTG~GTACCCACCAAAGTGTTT~TCTTGGGGTATATCGACGTGAAGCAGTC~GTCCTAT 
Y L N W I G V P T K V F N L G V Y R R E A V K S Y  88 
I Exon  5 
301 CAGTCTTATGATTTCTTTC~CATGAC~TG~GAGGCTATGAA~TCCGCAAACAGTGTGCTCTGGTGGCACTG 
Q S Y D F F R H D N E E A M K I R K Q C A L V A L I I 3  
I Exon  6 
376 GAA~TGTTAAAGCCTATTTTACTGAAGA~GTGGGCA~TTGCGGTGTTT~TGCCACC~TACCACTCGG~G 
E D V K A Y F T E E S G Q I A V F D A T N T T R E I 3 8  
I Exon  7 
451 AGGAGGGACAT~TTTTG~CTTTGCC~GCAGAATGCCTTC~GGTATTCTTTGTAGAATCTGTCTGTGAT~T 
R R D M I L N F A K Q N A F K V F F V E S V C D D I 6 3  
Exon  8 
526 CCTGATGTCATTGCTGCC~TATTCTGGAGGTAAAAGTGTC~GCCCT~CTACCCCGAAAGG~TAGGGAGAAT 
P D V I A A N I L E V K V S S P D Y P E R N R E N I 8 8  
601 GT GATGGAGGAC TT CCTGAAGAGAAT  GAGTGCTACAAGGTCAC T TAC CAGCCCCT T GACCCAGACAACTAT GAT 
V M E D F L K R I E C Y K V T Y Q P L D P D N Y D 213 
I Exon  9 
676 AAGGAC C T CT CGT T CATAAAGGT GAT GAAT GTAGGCCAGAGAT TTC T GGT CAACAGAGT CAGGACTACATCCAG 
K D L S F I K V M N V G Q R E L V N R V Q D Y I Q 238 
751 AGTAAGAT TGT CTACTACCTGATGAACAT CCATGTCCATCCTCGCACCATCTACCT T  GCCGGCACGGAGAGAGC 
S K I V Y Y L M N I H V H P R T I Y L C R H G E S 263 
I Exon  i0 
826 GAGT T CAAT C T TT T GGGAAAGAT  GGGGGT GACTCTGGCCTCT CCGT GCGAGGAAAGCAGTT  GCT CATGCTCTG 
E F N L L G K I G G D S G L S V R G K Q F A H A L 288 
901 AAGAAGT T TCT GGAGGAACAGGAGAT CCAGGACCTTAAAGT GTGGACGAGCCAGT TGAAGAGGACAAT TCAGACT 
K K F L E E Q E I Q D L K V W T S Q L K R T I Q T 313 
I Exon  II 
976 GCTGAGTCT CTT GGGGTGAC TAT GAGCAGTGGAAGATCCTCAAT GAGAT T GATGCT GGCGT GTGTGAGGAGAT G 
A E S L G V T Y E Q W K I L N E I D A G V C E E M 338 
1051 ACATATT CAGAGAT T GAGCAACGGTACCCAGAGGAAT TT GCACT CCGAGAT CAAGAGAAGTATCT GTACCGATAC 
T Y S E I E Q R Y P E E F A L R D Q E K Y L Y R Y 363 
I Exon  12 
1126 C CTGGT GGGGAGT CCTACCAGGACCT GGTGCAGCGGCT GGAGCCT GTCAT CAT GGAGC TAGAGCGT CAAGGCAAC 
P G G E S Y Q D L V Q R L E P V I M E L E R Q G N 388 
E 
1201 ATCCTCGTTATCTCTCACCAGGCTGTCATGCGCTGCCTCCTGGCCTACTTCTTGGATAAAGGCGCAGATGAGTTA 
I L V I S H Q A V M R C L L A Y F L D K G A D E L 413 
Exon 13 I Exon  14 
1276 CCATACTTGAGGTGCCCCCTGCACATCATCTTCAAACTTACTCCTGTGGCCTATGGTTGCAAAGTGGAAACAATT 
P Y L R C P L H I I F K L T P V A Y G C K V E T I 438 
I Exon  15 
1351 ACT CT GAAT GT GGAT GCT GTAGACACACAT CGT GACAAGCCAACT CACAACT T CCCCAAGAGCCAAACCCCT GTA 
T L N V D A V D T H R D K P T H N F P K S Q T P V 463 
1426 
1501 
1576 
AGGAT GAGAAGGAACAGC T T TACGCCT CT GT CCAGT TCGAACACAATAAGGCGTCCAAGAAATTACAGTGT  GG 
R M R R N S F T P L S S S N T I R R P R N Y S V G 
AGCCGACC CCT CAAGCCCCT CAAGC CT CT C CGTGC TCTGGACATGCAAGAAGGGGCT GACCAGCCGAAGACCCAA 
S R P L K P L K P L R A L D M Q E G A D Q P K T Q 
GTCAGCATTCCGGTGGTGTAAct  g gtgt t t cct ccagct t tggcct ct tgccct t gccact aat caaccaagaa 
V S I P V V * 
1651 gtcatttaacttccccccactcctgtcccaacgttaatctgaaaacagaatctgagctcatgcgtgtgcagagca 
1726 gcctcagccattctctaggtaaacacgtcacccgggggcaagatggcaagttgggtctttagacatgtccccaga 
1801 tgggatgatctgaaagaagaggagccaagcatgagtcatagacttggttcttctgtttcctgatgtctgacccca 
1876 gtc tgtgaagtc tgtgtgtgtgtgtatgtgtgtgtatgtatgtatgcatgtgtgccg  
488 
513 
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Fig. 2. Test of 2kbC5 3' sequence by PCR. (Top) Schematic repre- 
sentation of experiment. (i) Expected PCR products if 2kbC5 is an 
aberrant clone; (ii) expected PCR products if 2kbC5 represents an 
actual transcript. Genomic structure (with extended exon 15 sug- 
gested by this study, indicated by striped box) and mouse cDNA 
(a) are based on the rat heart gene [11]. (Bottom) PCR products 
separated on a 1% agarose gel and stained with ethidium bromide. 
PCR amplification on genomic mouse template (RAG), an inde- 
pendent mouse brain cDNA preparation, and the original 2kbC5 
clone was tested using both exon 7-8 control primers and 3' inlro- 
nic primers. The control reaction using exon 7-8 primers yielded 
bands of the expected size in genomic (1106 bp) and spliced cDNA 
(171 bp) templates and showed that the cDNA preparation was not 
contaminated with genomic DNA. Products of the expected 389 bp 
size were obtained in all samples using the 3' intronic primers. 
observed in the cDNA preparation as only one processed 
band was present (Fig. 2, bottom). 
3.3. Comparison of predicted protein sequences q[ isozymes 
The predicted amino acid sequence of 2kbC5 encoded by 
the complete ORF  exhibits significant homology to previously 
characterized PFK-2/FBPase-2 isozymes (Fig. 3). The 2kbC5 
predicted protein is 82% homologous to rat liver [24], 83% 
homologous to rat testis [6], 96% similar to rat brain [8], 
99% homologous to a partial rat heart sequence [6] and 
93% homologous to bovine heart [26]. It therefore appears 
to represent a mouse heart-type isozyme. The active sites of 
the bifunctional enzyme are conserved between the various 
isozymes, while the sequences differ at the 5' and 3' ends 
due to differences in regulatory domains. 
3.4. Pattern of expression and size of transcript 
A Northern blot of poly-A+ enriched mRNA from various 
mouse tissues was probed with 2kbC5 (Fig. 4, top). A tran- 
script of about 8 kb was detected in multiple tissues, with the 
strongest signal in kidney, which most likely corresponds to 
the heart-type isozyme encoded by 2kbC5. The same probe 
detected two additional transcripts in multiple tissues, sized 4 
kb, 6 kb, as well as a larger 11 kb transcript in brain and 
skeletal muscle only, which may correlate with other alterna- 
tively spliced transcripts from the heart gene. In testis only, an 
additional 3 kb transcript was detected. Since a 3.3 kb mRNA 
has previously been observed in this tissue which is not de- 
rived from the testis-specific sozyme [6], this may correspond 
to the heart-type transcript specifically expressed in testis. The 
liver- and muscle-type isozymes had been observed to be 
smaller (2.1 2 kb and 1.9 kb, respectively) in previous studies 
[16,15,27] and no bands of corresponding sizes were detected 
by 2kbC5. 
4. Discussion 
In spite of the presumed similarity of its roles in kidney and 
liver, PFK-2/FBPase-2 expression has not been definitively 
studied in renal tissue. Screening of a kidney-specific adult 
mouse cDNA library with human liver PFK-2/FBPase-2 iso- 
lated two distinct cDNA clones, 500bC6 and 2kbC5. Prelimin- 
ary hybridization results and sequence homology to pre- 
viously characterized isozymes in other species suggested 
that these were derived from the X-linked and autosomal 
loci, respectively. The isolation of a transcript apparently de- 
rived from PFK-2/FBPase-2 gene A was an interesting finding 
since expression of the X-linked locus in kidney had been a 
matter of controversy. This disagrees with the findings [16,17] 
that gene A is not expressed in kidney, and supports the 
results which found liver and skeletal muscle isozymes present 
in renal tissue [14,15]. The isolation of distinct isozyme forms 
from separate loci indicates the complexity of the enzymatic 
organization in kidney and is striking in light of the enzyme's 
regulatory rather than functional role. 
Sequence and homology data of the 1932 bp mouse clone 
(2kbC5) indicated that it spans the entire open reading frame 
of a previously uncharacterized heart-type isozyme derived 
from gene B with a longer form of exon 15. The differential 
splicing implied by this result is supported by earlier charac- 
terization of the homologous bovine autosomal ocus which 
has been shown to encode at least five mRNAs [28]. Compar- 
ison of the mouse heart-type isozyme encoded by 2kbC5 with 
- -9  
Fig. 3. Comparison of protein sequence of mouse 2kbC5 to rat 
PFK-2/FBPase-2 isozymes. Alignment is shown for PFK-2/FBPase-2 
isozymes: partial rat heart-type sequence [6]; mouse 2kbC5; rat 
brain [8] and rat liver [24]. Amino acids which are identical between 
all four isozymes are enclosed in boxes. Shaded boxes contain con- 
served catalytic and substrate binding sites [12]. Using numbering 
based on rat liver sequence, these sites include: Arg452, Lys-356, 
and Arg-360, residues shown to bind substrate and/or product 
which are found on a surface loop of all mammalian FBPases; His- 
258, Glu-327 and His-392, a trio of catalytic residues in rat liver 
[30,12]; Arg-195, a key residue involved in Fru-6-P binding [31]; 
Arg-257 and Arg-307, which associate with the reactive C-2 phos- 
pho group of Fru-2,6-P2 [30,32]; and the ATP binding site, Gly- 
Leu-Pro-Ala-Arg-Gly-Lys-Thr [33]. Underlined residues represent 
potential phosphorylation sites. 
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the general information available for the bovine clones indi- 
cates that a similar transcript without exon 16 and an ex- 
tended version of exon 15 has been observed, although the 
predicted protein from the bovine sequence was 517 amino 
acids in comparison to the 519 amino acids predicted by the 
mouse clone (including initiation methionines). 
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
i 50 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ~LI~I~ 
• MSENSTFST EDSCNSSYKP HASNLRRAGK TCSWASYMT~ P~LI~I~I 
.MSENSTFST EDSSSSSYKP HASNLRRAGK KCSWASYMT~I > PILI%[~I~I 
MSREMGELTQ TRLQKIWIPH SSSSSVLQRR RG~SIPQFR]N~ P~MV]~F~V. 
51 
~ I  KLTRYLNWIG 
<LTRYLNWIG 
<LTRYLNWIG 
<LTRYLNWIG 
i01 ~ KF RKQCA LVALE D~KA~ K~RKQCA LVAL E DV[J~f I 
LFRKQCA LAALKDV~K~J 
151 
NAFi<VFF[~S I vFppFDvF9 
N~FW~rFs I vFpppvF~ 
HGY V~.~S ~ l~Jqp_J?E I LA ~ 
201 
N[QPLD 1 
251 
~LC~ ~.HGES~..~ 
301 
HM~ ~AE~ G~_VJ 
TKVFNL~V~~ 
TKVFNL~V 
TKVFNL~V 
TKVFNL~Q 
FTE~I~V FDATNTTRER 
FTE~3pI~V FDATNTTRER 
LSR~JE~V~V FDATNTTRER 
100 
S E 
150 
200 
ERN~ERN 
p~/~ DCD~_iy ] ~' 
DNY D  MN  L 
DNYp~DpS[[ K[MNVGp~[L 
DNY~DpS[[ K[MN[Gp~[L 
EEL~J~HS~[._~FD~J~M 
 FGGDSGLSF 
K~GGDSGLS~ 
R~GGDSGLS~ 
250 
K I V ~  
I KIV[YL~NIH I 
300 
[<[pEE~:~IpD 
K[p~IpD 
350 
TbQWK bE 
351 
~~L~I~ESY 'Q~LVQRLEPVIMELERQ~ 
L~RY~>ESYIQpLVQRLEPV IMELERQ~F 
L~!~ESYIQ~LVQRLEPV IMELERQ~ 
R~R~iP~ZSYIEpLVQRLEPV IMELERQ~_~ 
401 
LLAYFLDK~ A~ELPYL~P LH~IF~LTPV AYGC~I  F 
LLAYFLDK~ A~ELPYL~P LHFIF~LTPV AYGC~I  F 
LLAY LDK  SpELPYL FP LHFVLFLTPV AYGC !   
451 
400 
I 
LVI 
LVI 
LV I~4(~A~ 
500 ~ NNFPKS QTPVRMRRN~ FTPLSSSNTI RRPRNY~VGS RPLKPLSPLR HNFPKS QTPVRMRRNS FTPLSSSNTI RRPRNYSVGS RPLKPLKPLR EVENVL AKHRRPSMAS LTLLS* ........................ 
NV ..... DITREAEEA LDTVPAHY* ..................... 
Rat  Hear t  
Mouse  2kbC5 
Rat  Bra in  
Rat  L iver  
501 535 
ALDMQEGADQ PKTQVSIPVV ............... 
ALDMQZGADQ PKTQVSIPVV ............... 
172 R.S. Batra et al./FEBS Letters 393 (19961 16~173 
9.5kb - -  
7.5kb --  
4.4kb - -  
2.4kb - -  
~"- -K  
~-"T  
2kbC5 
9.5kb - -  
7.5kb - -  
4.4kb - -  
2.4kb - -  
1.35kb - -  
~-actin 
Fig. 4. Northern blot analysis of poly-A-enriched RNA isolated 
from multiple mouse tissues using mouse 2kbC5 cDNA probe (top) 
and 13-actin control probe (bottom). Prominent bands are indicated 
by arrows. 2kbC5 appears likely to have been derived from the ~ 8 
kb transcript (indicated as K) which has the strongest signal in kid- 
ney and may be the heart-type isozyme preferentially expressed in 
this tissue. T indicates a 3 kb band observed in testis only. Probing 
with [3-actin cDNA control probe revealed that loading of the skele- 
tal muscle track was significantly higher than in others. The actual 
representation f transcripts in this tissue may therefore be weaker 
than exhibited on the blot. Positions and sizes in kilobases of RNA 
ladder marker are indicated on the left. 
Compar ison of the protein sequence of the mouse heart- 
type isozyme with those of other PFK-2/FBPase-2 isozymes 
indicates that the active site residues are highly conserved 
between the isozymes with different regulatory domains at 
the N- and C-termini (Fig. 3). PFK-2/FBPase-2 catalytic 
and substrate binding site residues have been identified in 
rat liver [12] and the majority of these sites were found to 
be conserved throughout  he mammal ian isoforms, including 
the newly isolated mouse heart-type clone. Comparison of the 
predicted amino acid sequence of mouse heart-type clone to 
previously characterized PFK-2/FBPase-2 isozymes in other 
species reveals interesting homologies with respect to evolu- 
tion of the enzyme. The conservation and assembly of sepa- 
rate domains evidenced by the various isozyme forms makes a 
strong case to support  the exon shuffling hypothesis [11,29]. 
Future characterization of tissue-specific expression mechan- 
isms for PFK-2/FBPase-2 should yield fascinating insights 
into the evolution of the enzyme. 
The detection of multiple bands in Northern blots probed 
with the heart-type clone 2kbC5 is consistent with the identi- 
fication of at least five mRNAs  derived from gene B [28]. The 
entire PFK-2/FBPase-2 heart-type transcript predicted to cor- 
respond to 2kbC5 (due to its intense signal in kidney) detected 
on the Northern blot appeared to be approx. 8 kb, even 
though the coding region is confined to ,-~ 1.6 kb. This size 
discrepancy suggests a large untranslated region of the tran- 
script. 76 bp of untranslated exon 1 as well as 336 bp of 3' 
untranslated region have been isolated, yet the poly-A+ tail 
has not yet been reached nor has any polyadenylation signal 
(AATAAA)  been identified at the 3' end. Further character- 
ization of the untranslated regions may provide interesting 
insights into tissue-specific control of expression. 
Further studies of PFK-2/FBPase-2 expression in kidney 
are required to characterize thoroughly the multiple isozyme 
forms present in this tissue. This in turn should help to elu- 
cidate the overall organization of this complex regulatory sys- 
tem. 
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